Mason & Associates Inc Decreases Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Mason & Associates Inc reduced its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 9.6% during the fourth quarter, Holdings Channel.com reports. The institutional investor owned 432 shares of the medical equipment provider’s stock after selling 46 shares during the period. Mason & Associates Inc’s holdings in Intuitive Surgical were worth $225,000 as of its most recent filing with the SEC.

Other hedge funds have also added to or reduced their stakes in the company. Hazlett Burt & Watson Inc. grew its position in shares of Intuitive Surgical by 5.8% in the 3rd quarter. Hazlett Burt & Watson Inc. now owns 362 shares of the medical equipment provider’s stock worth $177,000 after buying an additional 20 shares during the period. Mitchell Mcleod Pugh & Williams Inc. lifted its holdings in shares of Intuitive Surgical by 4.1% during the third quarter. Mitchell Mcleod Pugh & Williams Inc. now owns 503 shares of the medical equipment provider’s stock valued at $247,000 after purchasing an additional 20 shares during the last quarter. Fragasso Financial Advisors Inc grew its stake in shares of Intuitive Surgical by 3.0% in the 4th quarter. Fragasso Financial Advisors Inc now owns 687 shares of the medical equipment provider’s stock worth $359,000 after buying an additional 20 shares during the last quarter. Ullmann Wealth Partners Group LLC raised its stake in Intuitive Surgical by 1.6% during the third quarter. Ullmann Wealth Partners Group LLC now owns 1,329 shares of the medical equipment provider’s stock valued at $653,000 after buying an additional 21 shares during the last quarter. Finally, Meeder Advisory Services Inc. increased its holdings in shares of Intuitive Surgical by 0.3% during the third quarter. Meeder Advisory Services Inc. now owns 7,386 shares of the medical equipment provider’s stock valued at $3,629,000 after acquiring an additional 22 shares in the last quarter. Institutional investors own 83.64% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts have issued reports on ISRG shares. Oppenheimer reaffirmed a “market perform” rating on shares of Intuitive Surgical in a report on Friday, October 18th. JPMorgan Chase & Co. boosted their price target on Intuitive Surgical from $495.00 to $575.00 and gave the stock an “overweight” rating in a research note on Friday, October 11th. Truist Financial lifted their price objective on Intuitive Surgical from $570.00 to $640.00 and gave the stock a “buy” rating in a report on Wednesday, December 18th. Robert W. Baird upped their target price on shares of Intuitive Surgical from $503.00 to $565.00 and gave the company an “outperform” rating in a research note on Thursday, October 17th. Finally, BTIG Research boosted their price objective on shares of Intuitive Surgical from $535.00 to $561.00 and gave the company a “buy” rating in a report on Tuesday, November 26th. One investment analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have given a buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $554.17.

Intuitive Surgical Price Performance

ISRG stock opened at $582.01 on Thursday. Intuitive Surgical, Inc. has a 1-year low of $355.17 and a 1-year high of $584.60. The business has a 50-day moving average price of $537.05 and a 200 day moving average price of $496.50. The company has a market capitalization of $207.30 billion, a P/E ratio of 93.57, a PEG ratio of 4.66 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.24 by $0.32. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. The firm had revenue of $2.04 billion for the quarter, compared to the consensus estimate of $2.01 billion. On average, analysts anticipate that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, CEO Gary S. Guthart sold 18,151 shares of the company’s stock in a transaction dated Wednesday, October 30th. The stock was sold at an average price of $511.63, for a total transaction of $9,286,596.13. Following the transaction, the chief executive officer now directly owns 24,219 shares of the company’s stock, valued at $12,391,166.97. This represents a 42.84 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. Also, CFO Jamie Samath sold 108 shares of the firm’s stock in a transaction dated Tuesday, November 26th. The stock was sold at an average price of $542.06, for a total value of $58,542.48. Following the completion of the sale, the chief financial officer now directly owns 8,757 shares of the company’s stock, valued at approximately $4,746,819.42. This represents a 1.22 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 48,190 shares of company stock worth $25,012,927 in the last three months. 0.80% of the stock is owned by insiders.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.